IndiaTickerAsston Pharmaceuticals Ltd - 544445 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Asston Pharmaceuticals
BSE:APL · ISIN INE0SJX01015
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Asston Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Notice Of Second Extraordinary General Meeting For F.Y. 2026-27 Scheduled To Be Held On 31St July, 2026 At 12:30 PMBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Meeting UpdatesBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Announcement Regarding Extraordinary General Meeting Of The Company.BSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Update On Board Meeting Scheduled To Be Held On 02Nd July, 2026.BSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Preferential IssueBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Board Meeting Outcome for Outcome Of The Board Meeting Scheduled To Be Held On 02Nd July, 2026.BSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Board Meeting Intimation for Board Meeting IntimationBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Audited Financial Results For The Financial Year Ended 31St March, 2026.BSE · financial results · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 29Th May, 2026BSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Audited Financial Results For The Financial Year Ended 31St March, 2026.BSE · financial results · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Board Meeting Intimation for Approving Audited Financial RessultsBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Shareholder Meeting / Postal Ballot-Outcome of EGMBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Record DateBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Notice Of Extraordinary General MeetingBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - The Extraordinary General Meeting Is Scheduled On Tuesday, 28Th April, 2026.BSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Meeting UpdatesBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Board Meeting Outcome for Outcome Of The Board Meeting Schedule To Be Held On 30Th March, 2026BSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Board Meeting Intimation for Scheduled To Be Held On 30Th March, 2026 At 3:00 P.M. At The Registered Office Of The CompanyBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Cancellation of Board MeetingBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Board Meeting Intimation for Increasing Of Authorised Capital And Raising Of FundsBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Commencement Of Commercial ProductionBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Meeting UpdatesBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Board Meeting Outcome for Outcome Of The Board MeetingBSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Board Meeting Intimation for Considering Loan Facility From HDFC Bank Ltd.BSE · exchange filing · pdf
Source filing Asston Pharmaceuticals Ltd - 544445 - Regulation 30 SEBI (LODR) Regulation Update.BSE · exchange filing · pdf
Source filing